BCO

Parks James K

Known title: EVPCIK: 0001839686

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 9, 2026

Brink's Gets CMA Approval for NCR Atleos Deal Remedy. Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.

this person other insiders at BCO

Transaction History

BCO▼ Sell$30K
BCO▲ Buy$0
BCO▼ Sell$31K
BCO▼ Sell$28K
BCO▼ Sell$10K
BCO▼ Sell$0
BCO▲ Buy$0
BCO▼ Sell$338K
BCO▲ Buy$0
BCO▼ Sell$78K
BCO▼ Sell$0
BCO▼ Sell$386K
BCO▼ Sell$28K
BCO▼ Sell$9K
BCO▼ Sell$0
BCO▲ Buy$0
BCO▼ Sell$24K
BCO▼ Sell$0
BCO▼ Sell$20K
BCO▼ Sell$0
BCO▼ Sell$210K
BCO▼ Sell$35K
BCO▼ Sell$0
BCO▲ Buy$0
BCO▼ Sell$6K
BCO▼ Sell$0
BCO▲ Buy$0
BCO▼ Sell$19K
BCO▼ Sell$0
BCO▼ Sell$16K
BCO▼ Sell$0
BCO▼ Sell$9K
BCO▼ Sell$72K
BCO▲ Buy$0
BCO▲ Buy$0
BCO▼ Sell$0
BCO▼ Sell$101K
BCO▼ Sell$6K
BCO▲ Buy$0
BCO▼ Sell$18K
BCO▼ Sell$11K
BCO▼ Sell$10K
BCO▲ Buy$0
BCO▼ Sell$68K

We use analytics to understand how market-wall is used. No personal data is sold.